novel coronavirus pneumonia (COVID-19)
Conditions
Interventions
Sponsors
Tongji Hospital, Tongji Medical College of HUST
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients who were confirmed diagnosis of 2019-ncov virus pneumonia, according to the "pneumonia diagnosis and treatment program for novel coronavirus infection (trial version 5)",including clinical symptoms, pulmonary CT manifestations and positive nucleic acid test; 2. Inpatients 18 years old (including 18), regardless of gender; 3. Willing to participate in this clinical trial and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with severe pneumonia requiring mechanical ventilation and severe new coronavirus infection with pneumonia; 2. Death is expected within 48 hours; 3. There is clear evidence of bacterial infection in respiratory tract infections caused by primary immunodeficiency disease, acquired immunodeficiency syndrome, congenital respiratory tract malformation, congenital heart disease, gastroesophageal reflux disease, pulmonary dysplasia and other basic diseases; 4 subjects with the following conditions: daily treatment of asthma, any other chronic respiratory diseases, respiratory bacterial infections such as suppurative tonsillitis, acute tracheal bronchitis, sinusitis, otitis media and other respiratory diseases that affect clinical trial evaluation.Chest CT confirmed the existence of severe pulmonary interstitial lesions, bronchiectasis and other basic pulmonary diseases; 5. According to the researcher's judgment, the previous or current diseases may affect the patient's participation in the trial or the outcome of the study, including malignant diseases, autoimmune diseases, severe malnutrition, liver and kidney diseases, blood diseases, nervous system diseases, and endocrine diseases;He is suffering from serious diseases that affect the immune system, such as human immunodeficiency virus (HIV) infection, or blood system, or splenectomy, organ transplantation, etc. Unable to cooperate in mental state, suffering from mental disease, unable to control, unable to express clearly; Allergic constitution (such as allergic to two or more drugs or food) or history of allergy to this product and conventional treatment drugs; 8. A history of substance abuse or dependence; 9. Pregnant or nursing women; 10. Other researchers consider it inappropriate to participate in clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Validity observation index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety observation index; | — |
Countries
China
Contacts
Public ContactLiu Dong
Institutional Review Board, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Outcome results
None listed